The reverse LICAP flap: A laterally based submammary perforator flap for breast reconstruction.
Breast reconstruction
LICAP flap
Perforator flap
Reverse LICAP flap
Journal
Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
04
01
2023
accepted:
02
05
2023
medline:
29
8
2023
pubmed:
18
6
2023
entrez:
18
6
2023
Statut:
ppublish
Résumé
The traditional donor sites for autologous breast reconstruction include the abdomen, thigh, buttock, and posterior thorax. Herein, we describe the use of the reverse lateral intercostal perforator (LICAP) flap originating from the submammary region as an option for breast reconstruction. Fifteen patients (30 breasts) were included in this retrospective review. The procedure was performed for immediate reconstruction following a nipple sparing mastectomy utilizing an inframammary incision or an inverted T pattern with preservation of the fifth anterior intercostal perforator (n = 8), volume replacement after implant explantation (n = 5), and partial lower pole resurfacing with exteriorization of a portion of the LICAP skin paddle (n = 2). Flap survival was achieved in all patients. Three flaps (10%) had 1-2 cm of intraoperative distal tip ischemia, which was managed by excision prior to inset and closure. At the 12-month postoperative follow-up, stable results with good nipple position, breast shape, and projection were achieved in all patients. The reverse LICAP flap is a safe, effective, and reliable option for breast reconstruction following mastectomy.
Identifiants
pubmed: 37331037
pii: S1748-6815(23)00296-6
doi: 10.1016/j.bjps.2023.05.042
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
157-164Informations de copyright
Copyright © 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Dr. Nahabedian is a consultant for Allergan/Abbvie and Stryker. The remaining authors have no potential conflicts of interest to disclose.